Motley Fool Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.57M | Buy |
|
|||||
|
2025
Q1 | $944K | Buy |
|
|||||
|
2024
Q4 | $875K | Sell |
|
|||||
|
2024
Q3 | $10.4M | Sell |
|
|||||
|
2024
Q2 | $12.4M | Buy |
|
|||||
|
2024
Q1 | $4.1M | Buy |
|
|||||
|
2023
Q4 | $4.25M | Sell |
|
|||||
|
2023
Q3 | $4.01M | Buy |
|
|||||
|
2023
Q2 | $297K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $349K | Sell |
|
|||||
|
2022
Q3 | $309K | Sell |
|
|||||
|
2022
Q2 | $322K | Buy |
|
|||||
|
2022
Q1 | $286K | Buy |
|
|||||
|
2021
Q4 | $8K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $391K | Buy |
|
|||||
|
2020
Q1 | $258K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $251K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $217K | Buy |
|